Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Use of Information Technology in the Prevention of Diabetes [NA]
This clinical trial update reports the completion of a study evaluating the use of information technology to prevent Type 2 diabetes mellitu…
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China
This clinical trial update describes an evaluation of the effectiveness of a treatment paradigm for newly diagnosed type 2 diabetes patients…
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China
This clinical trial update describes a comprehensive longitudinal cohort study in Type 2 Diabetes patients at high cardiovascular risk in Ch…
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Cohort Study in Type 2 Diabetes in China
An ongoing cohort study of Type 2 diabetes mellitus in China is sponsored by China Cardiometabolic Registries. The current trial status is u…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: NOX-E36 First-in-Human (FIH) Study [Phase 1]
A first-in-human Phase 1 trial of NOX-E36 by TME Pharma has completed, reporting initial safety and tolerability data across inflammatory-re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function [Phase 4]
Phase 4 clinical trial update assessing whether adding liraglutide to short-term insulin infusion improves long-term glycemic remission and …
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin [Phase 2]
A Phase 2 trial evaluating the effect of Exenatide on abdominal fat distribution in patients with Type 2 diabetes pretreated with metformin …
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
This clinical trial update reports the completion of a multiple ascending dose study (Phase 1/Phase 2) of NOX-E36 in healthy volunteers and …
-
FDA approval · 2013-02-13FDA Approved: PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic combination of pioglitazone hydrochloride and metformin hydrochloride (Aurobindo Pharma …
-
FDA approval · 2013-02-13FDA Approved: PIOGLITAZONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original ANDA for pioglitazone hydrochloride, a generic version of pioglitazone for treating typ…
-
FDA approval · 2013-02-13FDA Approved: PIOGLITAZONE HCL AND METFORMIN HCL — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original application for Pioglitazone hydrochloride and metformin hydrochloride tablets (gene…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy [Phase 4]
Phase 4 trial comparing vildagliptin and sitagliptin shows differences in their ability to lower fasting plasma glucose.
-
FDA approval · 2013-02-11FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET XR, the extended-release combination of sitagliptin and metformin hydrochloride, fro…
-
FDA approval · 2013-02-11FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS research · 2013-02-08Clinical Trial Update: Diurnal Triglyceridemia in Relation to Alcohol Intake
This completed clinical trial assessed diurnal triglyceride variation in relation to alcohol intake in adults, including individuals with hy…
-
FDA approval · 2013-02-07FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics [Phase 4]
Phase 4 trial evaluating whether adding insulin glargine and exenatide, alongside oral diabetes medications, improves blood sugar control an…
-
CLINICAL_TRIALS research · 2013-02-06Clinical Trial Update: Consumption of Whole Grains and Legumes Modulates the Genetic Effect of the APOA5 -1131C Variant [NA]
A completed clinical trial from Yonsei University evaluated whether consuming whole grains and legumes modulates the effect of the APOA5 -11…
-
FDA approval · 2013-02-06FDA Approved: PIOGLITAZONE — Original Application (NorthStar RxLLC)
FDA approved the original ANDA for Pioglitazone from NorthStar RxLLC, enabling a generic pioglitazone product to enter the market.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia [Phase 4]
A Phase 4 trial conducted by the Medical University of Graz evaluated the efficacy and usability of published best practices to control glyc…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Feasibility Study - Integrated Sensor and Infusion Set. Trial III [NA]
This update reports the completion of a feasibility trial evaluating an integrated sensor and infusion set for diabetes management.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Impact of GBS on CVD in Type 2 Diabetes Mellitus [NA]
A completed clinical trial sponsored by Duke University evaluating the impact of Guillain-Barré syndrome on cardiovascular disease in indivi…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes [NA]
A completed clinical trial comparing insulin glargine with oral antidiabetic drugs in newly diagnosed type 2 diabetes.
-
CLINICAL_TRIALS research · 2013-02-05Clinical Trial Update: Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4 [NA]
This clinical trial update describes the collection of performance data from an integrated sensor and infusion set in Trial 4 for diabetes. …
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients [Phase 2]
A Phase 2 safety and efficacy trial of JTT-130 in obese patients with Type 2 diabetes has completed.